The “gold mine” of data released by Public Health England on Tuesday examines who may need COVID-19 booster shots. Financial Times‘John Burn Murdoch Report..
Analyzing the numbers on a series of charts, Burn-Murdoch explains that both the Pfizer-BioNTech vaccine and the AstraZeneca vaccine, which are the predominant shots in the UK, have generally been well tolerated by the symptomatic coronavirus. increase. Infection, hospitalization, When Dead (number) Even if the Delta variant takes over. There are signs of weakened immunity over time, but the decline is more pronounced among older people, especially those with underlying health.
It left two important points for Burn Murdoch. The study also suggests that “not everyone needs a booster” and that additional doses “can make a big difference” for people with comorbidities.
That idea seems to be in contrast to what is happening in Israel. Israel encourages everyone to receive a third dose of Pfizer vaccine (and even prepare for a fourth possibility) because of the more dramatic signs, regardless of additional factors. Immune weakness.But Burn Murdoch Insist The new data support the theory that longer intervals between doses deployed by the United Kingdom set steps for better long-term protection than shorter breaks taken by Israel and the United States.
The good news is that the Israeli booster campaign is working well. Therefore, it is worth monitoring what it says about maximizing vaccine efficacy in the future.
You may like it too